P

PVLA

Palvella Therapeutics Inc

156.13

Aug 14 • 3:59 PM ET -0.42 (-0.27%)

156.13

Aftermarket • 7:34 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS BMRN CRNX INCY AXSM NBIX

| Held by: XBI VTI IWM VXF IWO VTWO VHT VFMO LFSC SBIO

Scroll to Statements

Index	RUT
Market Cap	2.25B
Enterprise Value	2.02B
Income	-61.70M
Sales	0.00M
Book/sh	15.06
Cash/sh	17.39
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Jan 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	10.36
P/C	8.98
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	21.18
Current Ratio	21.18
Debt/Eq	0.10
LT Debt/Eq	0.10
Option/Short	Yes / Yes

EPS (ttm)	-4.84
EPS next Y	-7.81
EPS next Q	-1.77
EPS this Y	-75.53%
EPS next Y	-19.92%
EPS next 5Y	-11.12%
EPS past 3/5Y	53.08% 41.62%
Sales past 3/5Y	- -
EPS Y/Y TTM	61.66%
Sales Y/Y TTM	-
EPS Q/Q	-77.78%
Sales Q/Q	-
Earnings	Aug 04 BMO
EPS/Sales Surpr.	-29.55% -

Insider Own	36.11%
Insider Trans	-0.36%
Inst Own	90.62%
Inst Trans	33.38%
ROA	-37.70%
ROE	-46.63%
ROIC	-25.78%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	6.12%
SMA50	13.64%
SMA200	37.58%
Trades

Shs Outstand	14.40M
Shs Float	9.21M
Short Float	22.46%
Short Ratio	8.16
Short Interest	2.07M
52W High	161.38 -3.25%
52W Low	41.71 274.32%
Volatility	3.94% 7.32%
ATR (14)	8.89
RSI (14)	57.74
Beta	-0.22
Rel Volume	0.43
Avg Volume	253.43K
Volume	109,815

Perf Week	-1.04%
Perf Month	5.66%
Perf Quarter	31.23%
Perf Half Y	90.36%
Perf YTD	49.16%
Perf Year	238.68%
Perf 3Y	736.17%
Perf 5Y	-49.18%
Perf 10Y	12.16%
Recom	1.00
Target Price	229.82
Prev Close	156.55
Price	156.13
Change %	-0.27%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)